Mark A. Hardy

1.3k total citations
41 papers, 963 citations indexed

About

Mark A. Hardy is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark A. Hardy has authored 41 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark A. Hardy's work include Pancreatic function and diabetes (5 papers), Renal and Vascular Pathologies (4 papers) and Diabetes and associated disorders (3 papers). Mark A. Hardy is often cited by papers focused on Pancreatic function and diabetes (5 papers), Renal and Vascular Pathologies (4 papers) and Diabetes and associated disorders (3 papers). Mark A. Hardy collaborates with scholars based in United States, Canada and United Kingdom. Mark A. Hardy's co-authors include Allan L. Goldstein, Arabinda Guha, Abraham White, Marion M. Zatz, David J. Cohen, Julian Mackay‐Wiggan, Marc E. Grossman, Elizabeth Knobler, Michael J. Goldstein and Warren D. Widmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Mark A. Hardy

40 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Hardy United States 16 202 197 181 134 133 41 963
Ivo P. Torres Filho United States 23 292 1.4× 274 1.4× 189 1.0× 137 1.0× 135 1.0× 56 1.8k
Xuemei Hu China 19 219 1.1× 148 0.8× 511 2.8× 75 0.6× 129 1.0× 91 1.3k
Parag Kumar United States 18 82 0.4× 285 1.4× 88 0.5× 194 1.4× 112 0.8× 43 1.2k
Seiji Saito Japan 22 320 1.6× 302 1.5× 73 0.4× 95 0.7× 62 0.5× 114 1.3k
Sabine Horn Austria 15 109 0.5× 222 1.1× 135 0.7× 151 1.1× 101 0.8× 43 915
Davor Brinc Canada 19 125 0.6× 282 1.4× 224 1.2× 323 2.4× 71 0.5× 54 1.5k
Qianli Ma China 23 151 0.7× 428 2.2× 69 0.4× 97 0.7× 233 1.8× 106 1.5k
Keith Burling United Kingdom 23 187 0.9× 509 2.6× 50 0.3× 174 1.3× 141 1.1× 65 1.6k
Georgios Dimitriadis Greece 17 243 1.2× 330 1.7× 31 0.2× 111 0.8× 220 1.7× 71 1.2k
Richard Wahl Germany 15 160 0.8× 386 2.0× 199 1.1× 101 0.8× 115 0.9× 54 1.2k

Countries citing papers authored by Mark A. Hardy

Since Specialization
Citations

This map shows the geographic impact of Mark A. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Hardy more than expected).

Fields of papers citing papers by Mark A. Hardy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Hardy. The network helps show where Mark A. Hardy may publish in the future.

Co-authorship network of co-authors of Mark A. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Hardy. A scholar is included among the top collaborators of Mark A. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Hardy. Mark A. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hardy, Mark A., et al.. (2021). Manifestation of Nonuremic Calciphylaxis in the Extremities: Case Report and Review. The Journal of Foot & Ankle Surgery. 61(5). e41–e47. 2 indexed citations
4.
Rahim, Hussein, Shmuel Chen, Aaron Crowley, et al.. (2019). TCT-30 Ultra-Low Contrast Coronary Angiography in Patients With Advanced Chronic Kidney Disease: Feasibility and Outcomes Compared With Conventional Angiography. Journal of the American College of Cardiology. 74(13). B30–B30. 4 indexed citations
5.
Rahim, Hussein, Akiko Maehara, Gary S. Mintz, et al.. (2019). Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery. Coronary Artery Disease. 30(5). 346–351. 8 indexed citations
6.
Hardy, Mark A., et al.. (2018). Charcot Pathogenesis: A Study of In Vivo Gene Expression. The Journal of Foot & Ankle Surgery. 57(6). 1067–1072. 10 indexed citations
7.
Hardy, Mark A., et al.. (2013). Chondromyxoid Fibroma of the Calcaneus: Two Case Reports and Literature Review. The Journal of Foot & Ankle Surgery. 52(5). 643–649. 10 indexed citations
8.
Hardy, Mark A., et al.. (2011). Multiplanar Phalangeal and Metatarsal Osteotomies for Hallux Rigidus. Clinics in Podiatric Medicine and Surgery. 28(2). 329–344. 20 indexed citations
9.
Raffo, Anthony J., Kolbe Hancock, Yuli Xie, et al.. (2008). Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. Journal of Endocrinology. 198(1). 41–49. 36 indexed citations
10.
Hardy, Mark A., et al.. (2007). Principles of Arthrodesis and Advances in Fixation for the Adult Acquired Flatfoot. Clinics in Podiatric Medicine and Surgery. 24(4). 789–813. 4 indexed citations
11.
Witkowski, Piotr, Tetsunori Seki, Guosheng Xiang, et al.. (2007). A DNA Enzyme Against Plasminogen Activator Inhibitor- type 1 (PAI-1) Limits Neointima Formation After Angioplasty in an Obese Diabetic Rodent Model. Journal of Cardiovascular Pharmacology. 50(6). 633–640. 7 indexed citations
12.
Maffei, Antonella, Zhuoru Liu, Piotr Witkowski, et al.. (2004). Identification of Tissue-Restricted Transcripts in Human Islets. Endocrinology. 145(10). 4513–4521. 77 indexed citations
13.
Goldstein, Michael J., Eugene S. Kim, Warren D. Widmann, & Mark A. Hardy. (2004). A 360° evaluation of a night-float system for general surgery: A response to mandated work-hours reduction. Current Surgery. 61(5). 445–451. 57 indexed citations
14.
Mackay‐Wiggan, Julian, David J. Cohen, Mark A. Hardy, Elizabeth Knobler, & Marc E. Grossman. (2003). Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). Journal of the American Academy of Dermatology. 48(1). 55–60. 127 indexed citations
15.
16.
Binah, Ofer, Honglu Zhang, Soji F. Oluwole, et al.. (1991). MECHANICAL AND ELECTROPHYSIOLOGIC CHANGES IN RAT CARDIAC ALLOGRAFTS DURING IMMUNOLOGIC REJECTION. Transplantation. 52(3). 508–512. 9 indexed citations
17.
Oluwole, Soji F., Ah‐Kau Ng, K Reemtsma, & Mark A. Hardy. (1989). THE MECHANISM OF THE INDUCTION OF IMMUNOLOGIC UNRESPONSIVENESS TO RAT CARDIAC ALLOGRAFTS BY RECIPIENT PRETREATMENT WITH DONOR LYMPHOCYTE SUBSETS. Transplantation. 48(2). 281–288. 18 indexed citations
18.
Oluwole, Soji F., K Reemtsma, & Mark A. Hardy. (1989). EFFECT OF ULTRAVIOLET B-IRRADIATED DONOR LEUKOCYTES AND PERITRANSPLANT CYCLOSPORINE ON CARDIAC ALLOGRAFT SURVIVAL IN PRESENSITIZED RATS. Transplantation. 48(5). 867–869. 3 indexed citations
19.
Buchthal, Steven D., Mark A. Hardy, & Truman R. Brown. (1988). Assessing the value of identifying the presence of malignant disease in human plasma by proton nuclear magnetic resonance spectroscopy. The American Journal of Medicine. 85(4). 528–532. 17 indexed citations
20.
Rettura, G, et al.. (1975). Brief Communication: Antitumor Action of Vitamin A in Mice Inoculated With Adenocarcinoma Cells2. JNCI Journal of the National Cancer Institute. 54(6). 1489–1491. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivo P. Torres Filho Breakdown of academic impact, for papers by Xuemei Hu Breakdown of academic impact, for papers by Parag Kumar Breakdown of academic impact, for papers by Seiji Saito Breakdown of academic impact, for papers by Sabine Horn Breakdown of academic impact, for papers by Davor Brinc Breakdown of academic impact, for papers by Qianli Ma Breakdown of academic impact, for papers by Keith Burling Breakdown of academic impact, for papers by Georgios Dimitriadis Breakdown of academic impact, for papers by Richard Wahl
Rankless by CCL
2026